Advances in Cancer Signal Transduction and Therapy

Advances in Cancer Signal Transduction and Therapy

Recent Advances in Signal Transduction Research and Therapy

Cancer is driven by numerous genetic and epigenetic changes occurring at the cellular level. These changes drive normal cells to proliferate and escape processes that usually regulate their ...
[view complete introduction]

US $
30

*(Excluding Mailing and Handling)



Role of NF-κB Activation in Multiple Myeloma and Other Hematological Malignancies

Pp. 114-130 (17)

DOI: 10.2174/9789811458118120010008

Author(s): Loukik Arora, Frank Arfuso, Alan Prem Kumar, Gautam Sethi

Abstract

NF-κB (nuclear factor kappa-light-chain-enhancer of activated B cells) is a rapid-acting transcription factor. It is present in almost all cell types and is one of the primary responders to several stimuli such as stress, cytokines, radiation, chemotherapeutic drugs, bacterial, and viral antigens. Aberrant regulation and activation of NF-κB have been implicated in several cancers, inflammatory and autoimmune disorders, viral infections, and erroneous immune system development. This chapter summarizes the role of NF-κB activation specifically in hematological malignancies and various strategies developed for its potential pharmacological intervention to abrogate the process of carcinogenesis.

Keywords:

Leukemia, Lymphoma, Myeloma, NF-κB, IKKs.